Literature DB >> 22375279

As Needed Use of Inhaled Corticosteroids for Management of Mild Persistent Asthma in Children.

Hengameh H Raissy, Kathryn Blake.   

Abstract

Entities:  

Year:  2011        PMID: 22375279      PMCID: PMC3281291          DOI: 10.1089/ped.2011.0123

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol Pulmonol        ISSN: 2151-321X            Impact factor:   1.349


× No keyword cloud information.
  14 in total

1.  Long-term effects of budesonide or nedocromil in children with asthma.

Authors:  Stanley Szefler; Scott Weiss; James Tonascia; N Franklin Adkinson; Bruce Bender; Reuben Cherniack; Michele Donithan; H William Kelly; Joseph Reisman; Gail G Shapiro; Alice L Sternberg; Robert Strunk; Virginia Taggart; Mark Van Natta; Robert Wise; Margaret Wu; Robert Zeiger
Journal:  N Engl J Med       Date:  2000-10-12       Impact factor: 91.245

Review 2.  Potential adverse effects of the inhaled corticosteroids.

Authors:  H William Kelly; Harold S Nelson
Journal:  J Allergy Clin Immunol       Date:  2003-09       Impact factor: 10.793

3.  Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.

Authors:  Christine A Sorkness; Robert F Lemanske; David T Mauger; Susan J Boehmer; Vernon M Chinchilli; Fernando D Martinez; Robert C Strunk; Stanley J Szefler; Robert S Zeiger; Leonard B Bacharier; Gordon R Bloomberg; Ronina A Covar; Theresa W Guilbert; Gregory Heldt; Gary Larsen; Michael H Mellon; Wayne J Morgan; Mark H Moss; Joseph D Spahn; Lynn M Taussig
Journal:  J Allergy Clin Immunol       Date:  2006-11-30       Impact factor: 10.793

4.  Effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home.

Authors:  B Volovitz; M Nussinovitch; Y Finkelstein; L Harel; I Varsano
Journal:  Clin Pediatr (Phila)       Date:  2001-02       Impact factor: 1.168

5.  Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.

Authors:  David P Skoner; Eli O Meltzer; Henry Milgrom; Paul Stryszak; Ariel Teper; Heribert Staudinger
Journal:  J Asthma       Date:  2011-08-22       Impact factor: 2.515

6.  Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.

Authors:  D B Allen; E A Bronsky; C F LaForce; R A Nathan; D G Tinkelman; M L Vandewalker; P Konig
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

7.  Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home.

Authors:  N M Wilson; M Silverman
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

8.  Prevention of viral induced asthma attacks using inhaled budesonide.

Authors:  G Connett; W Lenney
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

9.  Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children.

Authors:  Benjamin Volovitz; Efraim Bilavsky; Moshe Nussinovitch
Journal:  J Asthma       Date:  2008-09       Impact factor: 2.515

10.  Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections.

Authors:  J Svedmyr; E Nyberg; E Asbrink-Nilsson; G Hedlin
Journal:  Acta Paediatr       Date:  1995-08       Impact factor: 2.299

View more
  3 in total

1.  Personalized Medicine in Preschool Children with Asthma.

Authors:  Hengameh Raissy; Kathryn Blake
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2017-12-01       Impact factor: 1.349

2.  Inhaled corticosteroids in lung diseases.

Authors:  Hengameh H Raissy; H William Kelly; Michelle Harkins; Stanley J Szefler
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

3.  Does Use of Inhaled Corticosteroid for Management of Asthma in Children Make Them Shorter Adults?

Authors:  Hengameh H Raissy; Kathryn Blake
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2013-06       Impact factor: 1.349

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.